Sumitomo Chemical India Ltd. · NSE:SUMICHEM

Sumitomo Chemical India — FY2021 Earnings Presentation

42 slides from Sumitomo Chemical India's earnings presentation, May 31, 2021

  1. Slide 1: Exchange filing cover letter

    SCIL/SEC/2021 31st May, 2021 To, BSE Limited, The National Stock Exchange of Listing Department, India Listing Department, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex Mumbai-400001 Bandra East, Mumbai - 400 051 Dear Sirs, Sub: Investor Presentation on Financial Resu

  2. Slide 2: Sumitomo Chemical India Limited Investor Presentation May 2021

    Sumitomo Chemical India Limited Investor Presentation May 2021

  3. Slide 3: Safe Harbour

    Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Sumitomo Chemical India Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for

  4. Slide 4: Financial Performance & Key Highlights

    Financial Performance & Key Highlights 3

  5. Slide 5: Performance Highlights – Quarter & Full Year

    Performance Highlights – Quarter & Full Year Revenue (Rs Crs) Gross Profit (Rs. Crs) & EBITDA (Rs. Crs) & PAT (Rs Crs) Gross Profit Margin (%) EBITDA Margin (%) +23% +72% +136% +20% Quarter 193 71 54 534 447 157 41 23 35.1% 36.2% 13.4% 5.1% 9.3% 10.1% Q4FY20 Q4FY21 Q4FY20 Q4FY21 Q4FY20 Q4FY21 Q4FY20

  6. Slide 6: Performance Highlights – Full Year

    Performance Highlights – Full Year Key Highlights ✓ COVID-19 1st wave SCC Responsible Care Awards 2021 ▪ Production lost during few initial weeks of Q1 FY21 ▪ Subsequently production resumed and ramped up gradually over the period ✓ 2nd wave of COVID-19 has impacted operations in Q1 FY22 but not mat

  7. Slide 7: Consolidated Profit & Loss Account Statement – Quarter & YTD

    Consolidated Profit & Loss Account Statement – Quarter & YTD Quarter Full Year Particulars (Rs. Crs) Q4 FY21 Q4 FY20 YoY FY21 FY20 YoY Revenue from Operations 534.3 446.7 20% 2,644.9 2,424.8 9% COGS 340.9 289.8 1,655.4 1,607.6 Gross Profit 193.3 156.9 23% 989.5 817.2 21% Gross Profit % 36.2% 35.1% 1

  8. Slide 8: Revenue Breakup – Full Year

    Revenue Breakup – Full Year Product Breakup Geographic Breakup 7% 7% 4% 1% 2% 1% 11% 11% 3% 3% 2% 3% 2% 4% 5% 0% 6% 7% 7% 47% 45% FY20 FY21 FY20 FY21 10% 11% 80% 83% 18% 19% Insecticides PGR Fungicides Domestic Japan Europe North America Herbicides Metal Phosphides AND & EHD* Africa Asia (Ex. India)

  9. Slide 9: Consolidated Balance Sheet

    Consolidated Balance Sheet Assets (Rs. Crs) Mar-21 Mar-20 Equity & Liabilities (Rs. Crs) Mar-21 Mar-20 Non-Current Assets (A) 365.7 360.6 EQUITY (A) 1,541.3 1,221.8 Property, Plant and Equipment 277.6 282.9 Equity Share Capital 499.1 499.1 Capital work-in-progress 4.3 6.5 Other Equity 1,042.2 722.6

  10. Slide 10: Consolidated Working Capital Movement

    Consolidated Working Capital Movement Change Change Particulars (Rs. Crs) Mar-21* Mar-20* (Mar-21 to Dec-20* (Mar-21 to Mar-20) Dec-20) Inventory (A) 754.4 588.0 166.4 544.0 210.4 Inventory Days (Inventories/ COGS* No. of days in period) (i) 166 134 143 Trade Receivables (B) 848.2 849.8 -1.5 916.5 -

  11. Slide 11: Consolidated Cash Flow Statement

    Consolidated Cash Flow Statement Cash Flow Statement (Rs. Crs) Year ended 31-Mar-21 Year ended 31-Mar-20 Net Profit Before Tax 453.3 266.5 Adjustments for: Non-Cash Items / Other Investment or Financial Items 54.5 45.7 Operating profit before working capital changes 507.8 312.2 Changes in working ca

  12. Slide 12: Capex Plans

    Capex Plans Regular Capex Additional Capex Rs. 70-75 crore p.a. Rs. 100-110 crore over 1-2 years for 5 products Research & Development To manufacture additional proprietary technical Indian R&D team is working on manufacturing Maintenance capex grade active ingredients products for our parent severa

  13. Slide 13: Digital transformation & SAP Implementation

    Digital transformation & SAP Implementation Earlier SCIL was using different SAP platforms in different parts of business. From April 2021, SCIL has completed implementation of an integrated SAP SH4 HANA system across the entity including several additional modules Common SAP system across the entit

  14. Slide 14: Sumitomo Chemical Company Limited, Japan - An Introduction

    Sumitomo Chemical Company Limited, Japan - An Introduction

  15. Slide 15: Overview of our Parent Company

    Overview of our Parent Company About Sumitomo ✓ Sumitomo started business in Japan in early 16th Century (400 years+) ✓ Currently several Sumitomo founded companies operate as independent listed companies with widespread shareholding and run by its professional boards ✓ Even today, all Sumitomo comp

  16. Slide 16: SCC - Growth Strategy in Health & Crop Sciences Sector - R&D

    SCC - Growth Strategy in Health & Crop Sciences Sector - R&D Core Competence: R&D R&D performance data (Million US$) Crop Protection Sales & Number of Issued Patent (2012-2019) Sumitomo Chemical is conducting 14,000 12,600 Crop Protection Products Sales Numbers of Issued Patents R&D based on the kno

  17. Slide 17: SCC - Growth Strategy in Health & Crop Sciences Sector - Distribution

    SCC - Growth Strategy in Health & Crop Sciences Sector - Distribution Refer SCC, Japan IR presentation and Investor handbook 2020 at SCC website 16

  18. Slide 18: Sumitomo Chemical India Ltd. - Company Overview

    Sumitomo Chemical India Ltd. - Company Overview Journey to 11x Growth Formidable Player in the Indian SCIL - Vision & Mission in India Agrochemicals Space Diversified & De-risked Portfolio Strong Brand and Well- Strategically Located Across the Agro-Chem Value Entrenched Distribution Manufacturing F

  19. Slide 19: SCIL - Vision & Mission

    SCIL - Vision & Mission Vision & Values Mission Vision: Marketing and Sales: • To be a trusted market leader in Indian crop- • Further penetration into Indian market & take protection sector leadership; expand exports • To develop a vibrant corporate culture • Strengthen Sales Force, Distribution an

  20. Slide 20: Journey to 11x Growth in India

    Journey to 11x Growth in India Exploration Phase: 2000 – 2010 Manufacturing JV with New Acquired product - 2000 Chemi 2002 Started EHD (Public Health) 2005 ‘Sulfosulfuron’ Leader 2010 business rights from Monsanto Started Animal Nutrition SCIL incorporated in India as 2001 Started ASD business 2003

  21. Slide 21: Key Products

    Formidable Player in the Indian Agrochemicals Space 5 200+ Grown 11X+* over FY11-21 Manufacturing Brands Rs. Bn Facilities 13X 26.4 10+ 25+ / 200+ Technical Actives Patents / Registrations 14,000+ 1,500+ Distributors Employees Product Name Product Category Indicative Use Glyphosate Herbicide Tea Gar

  22. Slide 22: Diversified & De-risked Portfolio Across the Agro-Chem Value Chain

    Diversified & De-risked Portfolio Across the Agro-Chem Value Chain Well-Diversified across multiple dimensions Business Products Geographies Customers Crops Served Segments Diversified Portfolio Across Segments Geographic Diversification with Exports to over 60 countries Generics Speciality 7% 1% Au

  23. Slide 23: Strong Brand and Well-Entrenched Distribution Network

    Strong Brand and Well-Entrenched Distribution Network ✓ Strong brand with market leading position across various product categories 23 States 65+ Depots ✓ Dual brand portfolio can offer products at all price points serving multiple customer sub-segments 14,000+ ~40,000 ✓ In-depth knowledge of own re

  24. Slide 24: Expanding Brand Visibility and Connect

    Expanding Brand Visibility and Connect ✓ Wide range of generics and speciality products for Increased crop presence and providing crop protection solutions ✓ More than 1,400+ Relationship managers connecting to 1 million+ farmers throughout crop cycle ✓ Over 100 brands covering maximum of crops and

  25. Slide 25: Digital Marketing Initiatives

    Digital Marketing Initiatives Develop “Digital Marketing” as a parallel support to Traditional marketing system leading to improved sales. YouTube - Advantage ✓ Our Digital Assets : 23 websites, engaged with 5.6 million consumers in 2020-21. More than 31,000 subscribers http://www.danitolindia.com/

  26. Slide 26: Strategically Located Manufacturing Facilities

    Strategically Located Manufacturing Facilities Connectivity to Major Cities and Proximity to Main Highways, Ports Reduces Logistic Time and Costs Plant Location Area (acres) Segment Served Product Manufactured Manufacturing of Technical Grade Pesticides Technical Grade Products: Bhavnagar ~58 and Fo

  27. Slide 27: Strong Focus on R&D and Process Innovation

    Strong Focus on R&D and Process Innovation End-to-End Product Development Capabilities ✓ 3 fully equipped, DSIR approved R&D labs located at Mumbai, Bhavnagar and Gajod capable of synthesis, technical product and formulation development ✓ R&D Team comprises of 75+ qualified and dedicated engineers &

  28. Slide 28: Thrust on Safety, Health and Environment (SHE)

    Thrust on Safety, Health and Environment (SHE) Quality Certifications Ensure Consistent product quality and healthy working environment at manufacturing sites Abiding by SCC Japan’s EHS Policies ISO:9001:2015, ISO-14001:2015 and OHSAS18001:2007 for the manufacturing sites at Bhavnagar, Gajod, Tarapu

  29. Slide 29: Autonomous Board with Vast Industry Experience

    Autonomous Board with Vast Industry Experience Dr. Mukul Govindji Asher Preeti Gautam Mehta Chairman and Independent Director Independent Non-executive Director ▪ Professorial Fellow at Lee Kuan Yew School of Public Policy at ▪ 30 years of experience in corporate laws, foreign investment the Nationa

  30. Slide 30: Autonomous Board with Vast Industry Experience

    Autonomous Board with Vast Industry Experience Hiroyoshi Mukai Tadashi Katayama Masanori Uzawa Non-executive Director Non-executive Director Non-executive Director ▪ MBA from University of Virginia, USA and ▪ MBA from Vanderbilt University, U.S.A. a Bachelor’s degree from the University ▪ Associated

  31. Slide 31: Growth Strategies

    Growth Strategies Continued Investment in R&D and Pipeline Capacity Expansion Achieving Market Leadership in • Aim to invest in seamless integration of R&D between SCIL and SCC • units which would help improve our production processes, Driving operational efficiencies maintaining highest safety stan

  32. Slide 32: Historical Performance Highlights & Key Takeaways

    Historical Performance Highlights Financial Performance & Key Takeaways Key Takeaways

  33. Slide 33: Historical Performance Highlights

    Historical Performance Highlights Revenue (Rs Crs) EBITDA (Rs. Crs) & EBITDA Margin (%) PAT (Rs Crs) ✓ Good monsoon and availability +11% of water boosted farmer 2,645 487 345 sentiment and resulted in good 2,425 +31% +34% 2,228 growth in rabi season 2020 as 1,913 333 291 205 well as upcoming Kharif

  34. Slide 34: Consolidated Profit & Loss Account Statement

    Consolidated Profit & Loss Account Statement Particulars (Rs. Crs) FY21 FY20 FY19 FY18 Net Revenue from Operations 2,644.9 2,424.8 2,228.4 1,912.9* COGS 1,655.4 1,607.6 1,458.9 1,238.7 Gross Profit 989.5 817.2 769.6 674.2 Gross Profit % 37.4% 33.7% 34.5% 35.2% Employee Expenses 194.3 179.3 158.4 147

  35. Slide 35: Consolidated Balance Sheet

    Consolidated Balance Sheet Assets (Rs. Crs) Mar-21 Mar-20 Mar-19 Mar-18 Equity & Liabilities (Rs. Crs) Mar-21 Mar-20 Mar-19 Mar-18 Non-Current Assets (A) 365.7 360.6 318.3 312.7 EQUITY (A) 1,541.3 1,221.8 1,048.4 954.0 Property, Plant and Equipment 277.6 282.9 277.2 264.8 Equity Share Capital 499.1

  36. Slide 36: Consolidated Working Capital Movement

    Consolidated Working Capital Movement Change Particulars (Rs. Crs) Mar-21 Mar-20 Mar-19 (Mar-21 over Mar-19) Inventory (A) 754.4 588.0 680.6 73.8 Inventory Days (Inventories/ COGS*365) (i) 166 134 170 Trade Receivables (B) 848.2 849.8 671.0 177.2 Trade Receivables Days (Trade Receivables / Revenue*3

  37. Slide 37: Consolidated Cash Flow Statement

    Consolidated Cash Flow Statement Year ended Year ended Year ended Year ended Particulars (Rs. Crs) 31-Mar-21 31-Mar-20 31-Mar19 31-Mar-18 Net Profit Before Tax 453.3 266.5 259.8 221.0 Adjustments for: Non-Cash Items / Other Investment or Financial Items 54.5 45.7 18.6 9.6 Operating profit before wor

  38. Slide 38: Key Takeaways

    Key Takeaways Formidable Player in the Indian Experienced Management Team Well-diversified Product Portfolio Strong Brand and Well-Entrenched Agro-chem Space and Board of Directors Across Agro-Chem Value Chain Distribution Network ▪ Strong / leadership position across ▪ Strong management and ▪ Multi

  39. Slide 39: Annexures

    Awards & Accolades Annexures Details on Merger with Excel Crop Care Ltd.

  40. Slide 40: Awards & Accolades

    Awards & Accolades Jamnalal Bajaj Award for “Fair Business and Practices” Shramveer award for improvement of product efficiency received from national level Delhi First ever president’s gold shield for import substitution Vishwakarma Rashtriya Puraskar received for process development First award fo

  41. Slide 41: Merger of Excel Crop Care to Unlock Value

    Merger of Excel Crop Care to Unlock Value Successfully and smoothly completed the merger Pre-Merger Structure Post-Merger Structure SCC and its affiliates Public Shareholders SCC and its affiliates (Japan) 44.98% Public & Others (Japan) 35.03% Excel Crop Care (ECC) 75% 19.7% 100.00% 19.98% Sumitomo

  42. Slide 42: For further information, please contact

    For further information, please contact: Company : Investor Relations Advisors : Sumitomo Chemical India Limited Strategic Growth Advisors Pvt. Ltd. CIN: L24110MH2000PLC124224 CIN: U74140MH2010PTC204285 Mr. Jigar Kavaiya +91 99206 02034 investor.relations@sumichem.co.in jigar.kavaiya@sgapl.net www.s

Sumitomo Chemical India — FY2021 Earnings Presentation on 6ix